Altor BioScience Corporation (Altor), a leading developer of cancer immunotherapeutics, announced enrollment is complete for the first cohort in a Phase 1b/2 trial using ALT-803, a proprietary interleukin-15 (IL-15) superagonist protein complex, in combination with the approved anti-PD-1 antibody (Ab) nivolumab (Opdivo®; Bristol-Myers Squibb) for patients with pre-treated, advanced, or metastatic non-small cell lung cancer (NSCLC). This Investigator-Sponsored Trial is being conducted under the direction of John Wrangle, M.D., M.P.H., at the Medical University of South Carolina (MUSC).Read More
Cancer MoonShot 2020 announced the formation of the Melanoma and Sarcoma Working Group to accelerate molecular-informed immunotherapy trials and to focus on identifying the most effective, cancer-directed immunotherapy treatments for patients with melanoma and sarcoma.Read More
Cancer MoonShot 2020 announced the formation of the Head and Neck Working Group which will work to identify and develop the most effective cancer-directed immunotherapy treatments for Head and Neck cancers. Read the full press release HERE.
Cancer MoonShot 2020 announced the formation of the Breast Cancer Working Group which will work to identify and develop the most effective cancer-directed immunotherapy treatments for breast cancer.Read More
Dr. Patrick Soon-Shiong CEO of NantWorks and founder of Cancer Moonshot 2020, announced that a novel genetically engineered adenovirus vaccine designed to treat colon cancer showed, in Phase II testing, a more than doubling of survival rate, with little to no toxicity. Promising results show some patients alive now more than five years after receiving the colon vaccine while on no other therapy.
NantHealth, LLC, announced the expanded adoption of GPS Cancer, a unique comprehensive molecular test to help oncology care providers guide treatment strategies for cancer care, by partnering with major self-insurers that have agreed to cover the costs for their employees requiring this test. Bank of America, Phoenix Children’s Hospital, Sanford Health will become the first national and regional self-insured employers to cover next-generation whole genome sequencing and proteomics for various cancers.
U.S. Vice President Joe Biden and Pope Francis made separate but similar calls for better global coordination, research and care in treatment of cancer at a Vatican event Friday in an evocative and unprecedented collaboration of political and religious efforts to mitigate the disease.
Speaking one after another in front of a massive bronze depiction of Christ's resurrection in the Vatican's Paul VI Hall, both Biden and Francis used spiritual imagery to push the world to action during a regenerative medicine conference.Read More